Acta Medica Scandinavica · 1978 · 52 citations · 24 references
MedicinePharmacologyPharmacotherapyPulmonary Function TestingPulmonologyRespiratory PharmacotherapyChronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease PharmacotherapyObstructive Lung DiseaseRespiratory DiseaseProtease InhibitionProtease InhibitorsProtease TherapyProteolytic ActivityProteolytic Enzyme ActivationProteolytic Enzyme ActivitySecreted Proteases
Acta Medica ScandinavicaVolume 203, Issue 1-6 p. 449-455 Free Access Proteases and Protease Inhibitors in Chronic Obstructive Lung Disease Sten Eriksson, Sten Eriksson the Department of Internal Medicine, University of Lund, Malmö General Hospital, Malmö, SwedenSearch for more papers by this author Sten Eriksson, Sten Eriksson the Department of Internal Medicine, University of Lund, Malmö General Hospital, Malmö, SwedenSearch for more papers by this author First published: January/December 1978 https://doi.org/10.1111/j.0954-6820.1978.tb14906.xCitations: 40AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Abbreviations: α1-AT α1-antitrypsin α2-M α2-macroglobulin STIC serum trypsin inhibitory capacity. References 1 Barett, A. J. & Starkey, P. M.: The interaction of alpha-2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism. Biochem J 133: 709, 1973. CrossrefPubMedWeb of Science®Google Scholar 2 Eriksson, S.: Pulmonary emphysema and alpha1-antitrypsin deficiency. Acta Med Scand 175: 197, 1964. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 3 Eriksson, S.: Studies in α1-antitrypsin deficiency. Acta Med Scand (Suppl) 177: 432, 1965. Google Scholar 4 Fagerhol, M.: Genetics of the Pi-system. In: Pulmonary emphysema and proteolysis (ed. C. Mittman), pp. 123– 131. Academic Press, New York 1972. Google Scholar 5 Hance, A. J. & Crystal, R. G.: The connective tissue of the lung. Am Rev Resp Dis 112: 657, 1975. CASPubMedWeb of Science®Google Scholar 6 Harris, J. O., Olsen, G. N., Castle, J. R. & Maloney, A. S.: Comparison of proteolytic enzyme activity in pulmonary alveolar macrophages and blood leukocytes in smokers and nonsmokers. Am Rev Resp Dis 11: 579, 1975. Google Scholar 7 Hochstrasser, K., Reichert, R., Schwarz, S. & Werle, E.: Isolierung und Charakterisierung eines Proteaseninhibitors aus menschlichem Bronchialsekret. Hoppe Seylers Z Physiol Chem 353: 221, 1972. CrossrefCASPubMedWeb of Science®Google Scholar 8 Janoff, A. & Scherer, J.: Mediators of inflammation in leucocyte lysosomes: 9. Elastinolytic activity in granules of human polymorphonuclear leukocytes. J Exp Med 128: 1137, 1968. CrossrefCASPubMedWeb of Science®Google Scholar 9 Johansson, W. G. & Pierce, J. A.: Effects of elastase, collagenase and papain on structure and function of rat lungs in vitro. J Clin Invest 51: 288, 1972. CrossrefCASPubMedWeb of Science®Google Scholar 10 Kueppers, F. & Bearn, A. G.: A possible experimental approach to the association of hereditary α1-antitrypsin deficiency and pulmonary emphysema. Proc Soc Exp Biol 121: 1207, 1966. CrossrefCASPubMedWeb of Science®Google Scholar 11 Larsson, C., Eriksson, S. & Dirksen, H.: Smoking and intermediate alpha1-antitrypsin deficiency and lung function in middle-aged men. Br Med J 2: 922, 1977. CrossrefCASPubMedWeb of Science®Google Scholar 12 Laurell, C.-B.: Screening test for α1-antitrypsin deficiency. Scand J Clin Lab Invest 29: 247, 1972. CrossrefCASPubMedWeb of Science®Google Scholar 13 Laurell, C.-B. & Eriksson, S.: The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. Scand J Clin Lab Invest 15: 132, 1963. CASWeb of Science®Google Scholar 14 Laurell, C.-B. & Jeppsson, J.-O.: Protease inhibitors in plasma. In: The plasma proteins (ed. F. W. Putnam), pp. 229– 263. Academic Press, New York, San Francisco and London 1975. CrossrefGoogle Scholar 15 Lazarus, G. S., Brown, R. S., Daniels, J. R., et al.: Human granulocyte collagenase. Science 159: 1483, 1968. CrossrefCASPubMedWeb of Science®Google Scholar 16 Lestienne, P., Dimicoli, J.-L. & Bieth, J.: Trifluoroacetyl tripeptides as potent inhibitors of human leukocyte elastase. J Biol Chem 252: 5931, 1977. CASWeb of Science®Google Scholar 17 Lieberman, J.: Elastase, collagenase, emphysema and alpha1-antitrypsin deficiency. Chest 70: 62, 1976. CrossrefCASPubMedWeb of Science®Google Scholar 18 Lieberman, J. & Gawad, M. A.: Inhibitors and activators of leukocytic proteases in purulent sputum: Digestion of human lung and inhibition by α1-antitrypsin. J Lab Clin Med 77: 713, 1971. CASPubMedWeb of Science®Google Scholar 19 Mandl, I., Darnule, T. V., Fierer, J. A., et al.: Elastin degradation in human and experimental emphysema. Adv Exp Med Biol 79: 221, 1977. CrossrefCASPubMedGoogle Scholar 20 Morse, J. O., Lebowitz, M. D., Knudson, R. J. & Burrows, B.: Relation of protease inhibitor phenotypes to obstructive lung disease in a community. N Engl J Med 296: 1190, 1977. CrossrefCASPubMedWeb of Science®Google Scholar 21 Ohlsson, K. & Delshammar, M.: Interactions between granulocyte elastase and collagenase and the plasma proteinase inhibitors in vitro and in vivo. In: Dynamics of connective tissue macromolecules (ed. P. M. C. Burleigh & A. R. Poole), pp. 259– 275. North-Holland Publishing Co., Amsterdam 1975. Google Scholar 22 Ohlsson, K. & Olsson, I.: The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastases. Eur J Biochem 42: 519, 1974. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 23 Ohlsson, K. & Tegner, H.: Granulocyte collagenase, elastase and plasma protease inhibitors in purulent sputum. Eur J Clin Invest 5: 221, 1975. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 24 Senior, R. M., Bielefeld, D. R. & Starcher, B. C.: Comparison of the elastolytic effects of human leukocyte elastase and porcine pancreatic elastase. Adv Exp Med Biol 79: 249, 1977. CrossrefCASPubMedGoogle Scholar 25 Senior, R. M., Tegner, H., Kuhn, C., et al.: The induction of pulmonary emphysema with human leukocyte elastase. Am Rev Resp Dis 116: 469, 1977. CrossrefPubMedWeb of Science®Google Scholar 26 Sharp, H. L.: The current status of alpha-1-antitrypsin, a protease inhibitor, in gastrointestinal disease. Gastroenterology 70: 611, 1976. CASPubMedWeb of Science®Google Scholar 27 Tegner, H.: Quantitation of human granulocyte protease inhibitors in non-purulent bronchial lavage fluids. Acta Otolaryngol. Accepted for publication. Google Scholar 28 Umezawa, H. & Aoyagi, T.: Activities of proteinase inhibitors of microbiological origin. In: Proteinases in mammalian cells and tissues (ed. A. J. Barett), pp. 637– 662. North-Holland Publishing Co., Amsterdam, New York and Oxford 1977. Google Scholar Citing Literature Volume203, Issue1-6January/December 1978Pages 449-455 ReferencesRelatedInformation
24
Proteinases in mammalian cells and tissues
J. Kay · FEBS Letters · 1978 · 825 citations
MEDIATORS OF INFLAMMATION IN LEUKOCYTE LYSOSOMES
Aaron Janoff, Joel Scherer · The Journal of Experimental Medicine · 1968 · 452 citations · Full text
Life Sciences, Immunology, Pathology +16